Ayurvedic Supportive Care for Breast Cancer Patients in Mumbai: A CTRI-Registered Approach to Complementary Wellness

A breast cancer diagnosis changes the shape of a family's days almost overnight — appointments, treatment cycles, and a body that doesn't feel like it belongs to you anymore. Many patients and caregivers in Mumbai search for ways to support the body through this process, not to replace what the oncology team is already doing, but to stand alongside it.

Breast cancer is currently the most common cancer among Indian women, with cases projected to cross 238,000 in 2024 according to an ICMR analysis published in JAMA. Behind that number are patients navigating surgery, chemotherapy, radiation, and the fatigue, appetite loss, and recovery challenges that come with it — often while still running a household or a job.

This guide looks at where Ayurvedic supportive care fits into that picture: what it can realistically offer alongside conventional cancer treatment, what the evidence says so far, and what a family in Mumbai evaluating these options should know before choosing a provider. It also walks through Health Reactive India's CTRI-registered clinical study on Body Revival — a detail worth understanding in full, including its scope and limits, before drawing conclusions from it.

This article has been written with inputs from Dr. Hemant Kadam (BAMS) and medically reviewed by Dr. Farah Zariwala (BHMS).

A note on what this article is not: Ayurvedic supportive care is not a treatment or cure for cancer, and nothing here should be read as medical advice. Any decision to add a complementary therapy should be made in consultation with the treating oncologist.

What Does "Ayurvedic Supportive Care" Actually Mean for a Cancer Patient?

The phrase gets used loosely, so it's worth being precise. In an oncology context, Ayurvedic supportive care refers to Ayurvedic formulations and practices used alongside — never instead of — surgery, chemotherapy, radiation, or hormonal therapy prescribed by an oncologist. The goal is to support the body's general resilience during and after treatment, not to act on the tumour itself.

Ayurvedic supportive care is a complementary approach that works alongside conventional cancer treatment. It typically focuses on appetite, energy levels, digestion, and general wellbeing during and after therapy. It is most commonly used by patients who want additional support managing the physical toll of treatment, under their oncologist's awareness.

This distinction matters medically and legally. In India, the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertising any product as a cure or treatment for cancer. Ayurvedic manufacturers who market products responsibly — Health Reactive India included — position them explicitly as adjuvant or supportive care, not as oncology treatment.

Where Supportive Care Fits in the Treatment Timeline

Patients typically consider Ayurvedic supportive care at three points: before major treatment (to build baseline strength), during active treatment (to help manage side effects like fatigue or appetite loss), and in the recovery period after surgery or the completion of chemotherapy/radiation.

What It Cannot Do

It cannot shrink a tumour, replace chemotherapy or radiation, or substitute for a prescribed treatment protocol. Any Ayurvedic product or practitioner suggesting otherwise should be treated with caution — this is precisely the kind of claim the DMRA exists to prevent.

Understanding Health Reactive India's CTRI-Registered Clinical Study

Most Ayurvedic wellness products in India carry no clinical documentation beyond traditional-use claims. This is the single biggest gap between marketing language and medical evidence in the category — and it's the gap a CTRI registration is meant to close.

CTRI/2023/11/059465 is a clinical trial registered with the Clinical Trials Registry of India for Body Revival, Health Reactive India's Ayurvedic liquid formulation. It was a 44-patient, 12-week, open-label study conducted in post-surgical breast cancer patients at J.B. Roy State Ayurvedic Medical College & Hospital, Kolkata, and was completed in November 2024.

A few specifics matter for anyone evaluating this study honestly:

• Scope: The trial was conducted specifically in post-surgical breast cancer patients. Its findings cannot be generalised to other cancer types, other stages of treatment, or patients who haven't had surgery.
• Design: It was open-label, meaning both patients and investigators knew which treatment was being given — a study design that is useful for early clinical observation but carries more risk of bias than a blinded, placebo-controlled trial.
• Sample size: 44 patients is a modest cohort by clinical research standards, appropriate for an initial open-label study but not large enough to support broad efficacy claims.
• Publication status: The trial is registered on the public CTRI registry, which is a meaningful transparency step, but as of this writing its results have not yet been published in a peer-reviewed journal. Registration confirms the study happened and was conducted under CTRI oversight; it does not by itself substitute for peer review.

Why This Still Matters

Even with those limits stated plainly, a completed, CTRI-registered human trial — in a supportive-care category where most competitors offer none — is a meaningfully higher evidence bar than typical Ayurvedic wellness marketing. Families evaluating Body Revival or any similar product should ask providers directly: is there a registered trial, and can you tell me its scope? For Body Revival, the honest answer is: yes, and it was specifically in post-surgical breast cancer patients over 12 weeks.

Managing Cancer Treatment Side Effects: What Integrative Guidance Actually Recommends

Fatigue, appetite changes, nausea, and disrupted sleep are among the most commonly reported challenges during cancer treatment, and they're also where most complementary-care conversations start.

Cancer-related fatigue and treatment side effects are best managed through a combination approach — medical management from the oncology team, lifestyle measures like structured physical activity, and, where appropriate, complementary supportive therapies. No single intervention addresses every symptom, and any addition should be discussed with the treating physician first.

It's worth noting that the joint 2024 guideline from the American Society of Clinical Oncology (ASCO) and the Society for Integrative Oncology, published in the Journal of Clinical Oncology, specifically addressed exercise, diet, and integrative approaches for managing fatigue during and after cancer treatment — reflecting a broader shift in oncology toward formally acknowledging supportive and integrative measures as part of comprehensive cancer care, rather than treating them as separate from it.

Practical Areas Where Patients Commonly Seek Support

• Appetite and nutrition: Treatment can suppress appetite for weeks at a time, and unintentional weight loss during chemotherapy is a genuine clinical concern that oncology teams monitor closely.
• Energy and fatigue: Persistent, treatment-related fatigue differs from ordinary tiredness and often doesn't resolve with rest alone.
• Digestive comfort: Nausea, altered taste, and digestive disruption are common, particularly during chemotherapy cycles.
• General resilience during recovery: After surgery or the completion of active treatment, many patients describe a slow rebuilding period where they're looking for steady, low-risk support.

These are the areas where Ayurvedic supportive formulations are typically positioned — not as symptom cures, but as one input among several a patient and their oncology team might consider.

Post-Surgical Recovery Support for Breast Cancer Patients

The period after breast cancer surgery — whether a lumpectomy or mastectomy — carries its own recovery demands, separate from any chemotherapy or radiation that follows.

Post-surgical recovery support for breast cancer patients generally combines the surgical team's wound-care and physiotherapy guidance with attention to nutrition, rest, and gradual return to activity. Complementary supportive care, when used, is typically introduced after the surgical team confirms it won't interfere with healing or any planned adjuvant therapy.

This is also the specific population Health Reactive India's CTRI-registered study examined — post-surgical breast cancer patients over a 12-week window — which is why the company positions the trial evidence for this stage of the journey specifically, rather than as general cancer-support evidence.

A Practical Checklist Before Adding Any Supportive Product Post-Surgery

1. Confirm timing and any interactions with your surgeon or oncologist before starting anything new
2. Ask for the product's composition and any available clinical documentation
3. Check that the manufacturer is AYUSH-registered and the product carries proper labelling
4. Treat any "cure" or "treatment" language as a red flag, not a selling point
5. Reassess if you notice any new symptoms after starting a supportive product, and inform your care team

Choosing an Ayurvedic Wellness Partner in Mumbai: What to Look For

Mumbai has no shortage of Ayurvedic wellness brands claiming to help cancer patients. Very few can point to a completed, registered clinical study. Here's what's worth checking before choosing one.

When evaluating an Ayurvedic supportive-care provider for cancer patients in Mumbai, check for AYUSH registration, ISO/GMP manufacturing certification, transparent ingredient disclosure, honest framing (supportive care, not treatment), and — ideally — some form of clinical documentation rather than testimonials alone.

Questions Worth Asking Any Provider

1. Is the manufacturer AYUSH-registered and GMP-certified?
2. Is there any clinical trial data, and if so, what was the study population and design?
3. Does the marketing language avoid "cure" or "treatment" claims for cancer specifically?
4. Is the formulation's composition disclosed, or is it vague about ingredients?
5. Is the brand upfront about the limits of what supportive care can and can't do?

Health Reactive India, founded in Mumbai in 1996, is an ISO and GMP-certified, AYUSH-registered manufacturer. Body Revival has supported over 1,00,000 patients as part of the company's broader immunity and wellness work, and the company's CTRI-registered trial in post-surgical breast cancer patients is, to date, an evidence credential most competitors in this category do not have.

Expert Perspective

"Supportive care has a real, specific role in the cancer journey — it works best when it's honest about its limits and transparent about its evidence. A registered clinical trial, even an early-stage one, is a meaningfully different starting point than traditional-use claims alone."

— Dr. Hemant Kadam, BAMS

Health Reactive India's own experience over three decades of formulation work is that families respond best to plain, unhurried explanations of what a product does and doesn't do — not urgency or promises. That's the framing this article, and the company's clinical positioning, is built around.

Ayurvedic supportive care has a defined, complementary role in the breast cancer journey — supporting appetite, energy, and general resilience alongside a conventional oncology treatment plan, never in place of one. Health Reactive India's CTRI-registered study (CTRI/2023/11/059465) on Body Revival, conducted in 44 post-surgical breast cancer patients over 12 weeks, is a genuine differentiator in a category where clinical documentation is rare — while still being an early-stage, open-label, not-yet-peer-reviewed study whose scope shouldn't be overstated. For families in Mumbai weighing these options, the right approach is the same one recommended throughout: talk to your oncology team first, and choose a provider that's transparent about both what it offers and what it doesn't.

Book a Free Consultation

If you'd like to understand whether Ayurvedic supportive care could complement your treatment plan, book a free consultation: https://healthreactive.co/bodyrevival

Author & Reviewer

Author: Dr. Hemant Kadam, BAMS

Medically Reviewed by: Dr. Farah Zariwala, BHMS